Sulfonylureas, Pioglitazone Similarly Safe for Add-On Therapy in Type 2 Diabetes (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD
For patients with type 2 diabetes inadequately controlled with metformin, add-on treatment with either a sulfonylurea or pioglitazone seems similarly safe over the long-term, according to an open-label, multicenter study in …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Actos | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Primary Care | Study